» Articles » PMID: 21994573

Molecular Mechanisms Underlying Hepatocellular Carcinoma

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2011 Oct 14
PMID 21994573
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocarcinogenesis is a complex process that remains still partly understood. That might be explained by the multiplicity of etiologic factors, the genetic/epigenetic heterogeneity of tumors bulks and the ignorance of the liver cell types that give rise to tumorigenic cells that have stem cell-like properties. The DNA stress induced by hepatocyte turnover, inflammation and maybe early oncogenic pathway activation and sometimes viral factors, leads to DNA damage response which activates the key tumor suppressive checkpoints p53/p21(Cip1) and p16(INK4a)/pRb responsible of cell cycle arrest and cellular senescence as reflected by the cirrhosis stage. Still obscure mechanisms, but maybe involving the Wnt signaling and Twist proteins, would allow pre-senescent hepatocytes to bypass senescence, acquire immortality by telomerase reactivation and get the last genetic/epigenetic hits necessary for cancerous transformation. Among some of the oncogenic pathways that might play key driving roles in hepatocarcinogenesis, c-myc and the Wnt/β-catenin signaling seem of particular interest. Finally, antiproliferative and apoptosis deficiencies involving TGF-β, Akt/PTEN, IGF2 pathways for instance are prerequisite for cancerous transformation. Of evidence, not only the transformed liver cell per se but the facilitating microenvironment is of fundamental importance for tumor bulk growth and metastasis.

Citing Articles

Network pharmacological evaluation of strigolactones efficacy as potential inhibitors against therapeutic targets of hepatocellular carcinoma.

Amod A, Pahal S, Choudhary P, Gupta A, Singh S Biotechnol Lett. 2022; 44(7):879-900.

PMID: 35672528 DOI: 10.1007/s10529-022-03266-7.


The IGF-1 Signaling Pathway in Viral Infections.

Jozefiak A, Larska M, Pomorska-Mol M, Ruszkowski J Viruses. 2021; 13(8).

PMID: 34452353 PMC: 8402757. DOI: 10.3390/v13081488.


miR-221-3p promotes hepatocellular carcinogenesis by downregulating O6-methylguanine-DNA methyltransferase.

Chen Z, Xiang B, Qi L, Zhu S, Li L Cancer Biol Ther. 2020; 21(10):915-926.

PMID: 33023393 PMC: 7644250. DOI: 10.1080/15384047.2020.1806642.


Antiproliferative and Pro-Apoptotic Effect of Uvaol in Human Hepatocarcinoma HepG2 Cells by Affecting G0/G1 Cell Cycle Arrest, ROS Production and AKT/PI3K Signaling Pathway.

Bonel-Perez G, Perez-Jimenez A, Gris-Cardenas I, Parra-Perez A, Lupianez J, Reyes-Zurita F Molecules. 2020; 25(18).

PMID: 32947962 PMC: 7571068. DOI: 10.3390/molecules25184254.


TCA Cycle Rewiring as Emerging Metabolic Signature of Hepatocellular Carcinoma.

Todisco S, Convertini P, Iacobazzi V, Infantino V Cancers (Basel). 2019; 12(1).

PMID: 31881713 PMC: 7016696. DOI: 10.3390/cancers12010068.


References
1.
Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T . AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet. 2000; 24(3):245-50. DOI: 10.1038/73448. View

2.
Heppner G . Tumor heterogeneity. Cancer Res. 1984; 44(6):2259-65. View

3.
Aikata H, Takaishi H, Kawakami Y, Takahashi S, Kitamoto M, Nakanishi T . Telomere reduction in human liver tissues with age and chronic inflammation. Exp Cell Res. 2000; 256(2):578-82. DOI: 10.1006/excr.2000.4862. View

4.
Wege H, Le H, Chui M, Liu L, Wu J, Giri R . Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology. 2003; 124(2):432-44. DOI: 10.1053/gast.2003.50064. View

5.
Longato L, de la Monte S, Kuzushita N, Horimoto M, Rogers A, Slagle B . Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver. Hepatology. 2009; 49(6):1935-43. PMC: 2754284. DOI: 10.1002/hep.22856. View